Contrasting actions of pressor agents in severe autonomic failure

American Journal of Medicine

Volumn 105, Issue 2, 1998, Pages 116-124

  Jordan, Jens ^a,b   Shannon, John R ^b   Biaggioni, Italo ^b   Norman, Riché ^b   Black, Bonnie K ^b   Robertson, David ^b  

^a FRANZ VOLHARD CLINIC   (Germany)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; FLUDROCORTISONE; GLUCOCORTICOID; IBUPROFEN; INDOMETACIN; METHYLPHENIDATE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLPROPANOLAMINE; PLACEBO; YOHIMBINE;

ADULT; AGED; ANOREXIA; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DYSPHORIA; FEMALE; HEADACHE; HUMAN; HYPOTENSION; MALE; ORTHOSTATIC HYPOTENSION; PRESSOR RESPONSE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

NASA DISCIPLINE REGULATORY PHYSIOLOGY; NON-NASA CENTER;

AGED; AUTONOMIC AGENTS; BLOOD PRESSURE; CAFFEINE; CATECHOLAMINES; FEMALE; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; IBUPROFEN; INDOMETHACIN; MALE; METHYLPHENIDATE; PHENYLPROPANOLAMINE; REGRESSION ANALYSIS; SINGLE-BLIND METHOD; YOHIMBINE;

EID: 0032144550     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00193-4     Document Type: Article

References (34)

1. 1. Robertson D. Treatment of cardiovascular disorders: orthostatic hypotension. In: Melmon KL, Morrelli HF, eds. Clinical Pharmacology Basic Principles in Therapeutics. New York: McGraw-Hill; 1992:84-103.
2. 2. Onrot J, Goldberg MR, Hollister AS, et al. Management of chronic orthostatic hypotension. Am J Med. 1986;80:454-464.
3. 3. Hickler RB, Thompson GR, Fox LM, Hamlin JT. Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone. NEJM. 1959;261:788-791.
4. 4. Freeman R. Midodrine and other presser drugs. In: Robertson D, Low PA, Polinsky RJ, eds. Primer on the Autonomic Nervous System. San Diego: Academic Press; 1996:334-336.
5. 5. Shannon JR, Jordan J, Costa F, et al. The hypertension of autonomic failure and its treatment. Hypertension. 1997;30:1062-1067.
6. 6. Chobanian AV, Volicer L, Tifft CP, et al. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. NEJM. 1979;301:68-73.
7. 7. Consensus Committee. The definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Autonom Nerv Sys. 1996;58:123-124.
8. 8. Goldstein DS, Polinsky RJ, Garty M, et al. Patterns of plasma levels of catechols in neurogenic orthostatic hypotension. Ann Neurol. 1989;26:558-563.
9. 9. Biaggioni I, Onrot J, Stewart CK, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA. 1987;258:236-239.
10. 10. Biaggioni I, Robertson RM, Robertson D. Manipulation of norepinephrine metabolism with yohimbine in the treatment of autonomic failure. J Clin Pharmacol 1994;34:418-423.
11. 2-adrenoreceptor responsiveness in autonomic dysfunction. J Am Coll Cardiol. 1984;3:850-856.
12. 12. Furlan R, Piazza S, Bevilacqua M, et al. Pure Autonomic Failure: complex abnormalities in the neural mechanisms regulating the cardiovascular system. J Autonom Nerv Sys. 1995;51:223-235.
13. N-cholinergic blockade in dissecting the components of cardiovascular regulation. Hypertension. 1998;32:101-107.
14. 14. Wilkinson GR, Beckett AH. Absorption, metabolism and excretion of the ephedrines in man. I. The influence of urinary pH and urine volume output. J Pharm Exp Ther. 1968;162:139-147.
15. 15. Sever PS, Dring LG, Williams RT. The metabolism of (-)-ephedrine in man. Euro J Clin Pharmacol. 1975;19;9:193-198.
16. 16. Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med. 1995;99:604-610.
17. 17. Food Advisory Committee Meeting. Clinical summaries of adverse event reports on dietary supplements that may contain ephedrine alkaloids. FDA, Docket No. 95N-0304. 1996;1-125.
18. 18. Hoffman BB, Lefkowitz RJ. Catecholamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill; 1996: 199-248.
19. 19. Onrot J, Goldberg MR, Biaggioni I, et al. Oral yohimbine in human autonomic failure. Neurology. 1987;37:215-220.
20. N-nicotinic blockade as an acute human model of autonomic failure. Hypertension. 1998;31: 1178-1184.
21. 21. Robertson D, Goldberg MR, Onrot J, et al. Isolated failure of autonomic noradrenergic neurotransmission: evidence of impaired β-hydroxylation of dopamine. NEJM. 1986;314:1494-1497.
22. 2-adrenergic receptors in humans. Hypertension. 1984;6:551-556.
23. 23. Goldberg MR, Robertson D, FitzGerald GA. Prostacyclin biosynthesis and platelet function in autonomic dysfunction. Neurology. 1985;35:120-123.
24. 24. Forman MB, Uderman H, Jackson EK, et al. Effects of indomethacin on systemic and coronary hemodynamics in patients with coronary artery disease. Am Heart J. 1985;110:311-318.
25. 25. Davies IB, Bannister R, Hensley C, Sever PS. The presser actions of noradrenaline and angiotensin II in chronic autonomic failure treated with indomethacin. J Clin Pharmacol. 1980;10:223-229.
26. 26. Onrot J, Goldberg MR, Biaggioni I, et al. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension. NEJM. 1985;313:549-554.
27. 27. Kaufmann K, Brannan T, Krakoff L, et al. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology. 1988;38:951-956.
28. 28. Robertson D. Pharmacology: assessment of autonomic function. In: Baughman KL, Greene BM, eds. Clinical Diagnostic Manual for the House Officer. Baltimore: Williams & Wilkins; 1981:86-101.
29. 29. Shannon JR, Robertson D. The clinical utility of plasma catecholamines. J Lab Clin Med. 1996;128:450-451.
30. 30. Jacob G, Ertl AC, Shannon JR, et al. Effect of standing on neurohormonal responses and plasma volume in healthy subjects. J Appl Physiol. 1998;84:914-921.
31. 31. Youmans JB, Wells HS, Donley D, Miller DG. The effect of posture (standing) on the serum protein concentration and colloid osmotic pressure of blood. J Clin Invest. 1934;13:447-459.
32. 32. Youmans JB, Akeroyd JH, Frank H. Changes in the blood and circulation with changes in posture. The effects of exercise and vasodilation. J Clin Invest. 1935;14:739-753.
33. 33. Brooks DJ, Redmond S, Mathias CJ, et al. The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine. J Neurol Neurosurg Psychiatry. 1989;52:962-966.
34. 34. Thomas DJ, Bannister R. Preservation of autoregulation of cerebral blood flow in autonomic failure. J Neurol Sci. 1980;44:205-212.